Ironwood Pharmaceuticals (IRWD) PT Raised to $27 at Mizuho Securities
Mizuho Securities raised its price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) to $27.00 (from $25.00) while maintaining a Buy rating.
Mizuho Securities raised its price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) to $27.00 (from $25.00) while maintaining a Buy rating.